PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study

Related articles

1. A Study on the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy in Patients with Oligometastatic Driver Gene-Negative Non-Small Cell Lung Cancer Undergoing Radiotherapy

   This article has 10 authors:

   1. Yang Liu
   2. Lingxiao Xie
   3. Jiaoyue Qu
   4. Quan Pan
   5. Zhao Yu
   6. Yin Yuan
   7. Chunyu Chang
   8. Hao Jiang
   9. Yuexin Yang
   10. Gengming Wang at

2. The Predictive efficacy of tumor mutational burden for immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials

   This article has 7 authors:

   1. Min Ying
   2. Mengyu Hu
   3. Kegui Weng
   4. Yanyan Long
   5. Jing Chen
   6. Qianqian Lei
   7. Yongzhong Wu

3. Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes

   This article has 23 authors:

   1. Kazuhiro Kou
   2. Mayu Fukuda
   3. Koji Yamanoi
   4. Nobutaka Hayashi
   5. Hisateru Yasui
   6. Takuma Hayashi
   7. Yoshihiro Yakushijin
   8. Takehiko Tsumura
   9. Atsushi Shirakawa
   10. Chiho Nakashima
   11. Yoshinori Imamura
   12. Chikako Yamauchi
   13. Toshio Shimizu
   14. Takahito Ashihara
   15. Nobuhiro Shibata
   16. Takeshi Kotake
   17. Aya Toyofuku
   18. Taito Miyamoto
   19. Rin Mizuno
   20. Mana Taki
   21. Ryusuke Murakami
   22. Manabu Muto
   23. Masaki Mandai